The present study examined the role of cytochrome P-450 metabolites of arachidonic acid in elevating renal vascular resistance in young spontaneously hypertensive rats (SHR). Differences in vascular tone were assessed in the preglomerular vasculature of 3-to 4-week-old prehypertensive SHR ( n = l l ) and normotensive Wistar-Kyoto (WKY, n=10) and Wistar-Lewis (n=10) rats. Pressure-diameter relations to changes in renal perfusion pressure were compared using the juxtamedullary nephron microvascular preparation perfused in vitro with a physiological salt solution. At a pressure of 60 mm Hg, the basal diameters of the interlobular arteries and proximal and distal afferent arterioles of the SHR averaged 43±2, 17±0.3, and 11 ±0.4 /u,m, respectively. The diameters of the interlobular arteries and afferent arterioles were 9% to 14% smaller than those of corresponding vessels in WKY and Wistar-Lewis rats. Addition of P-450 inhibitors, ketoconazole (100 /imol/L) or 7-ethoxyresorufin (1 /imol/L), to the perfusate dilated the afferent arteriole of SHR by 7% to 12%, whereas it increased the diameter by only 0% to 6% in control rats and significantly reduced the differences in the pressure-diameter relation in the preglomerular vasculature of SHR and control rats. Inhibitors of P-450 eliminated the contractile response of afferent arterioles to increases in renal perfusion pressure in all three groups. Removal of calcium from the perfusate eliminated differences in the diameters of the preglomerular vasculature in SHR and normotensive rats. Renal P-450 activities in SHR and normotensive rats were compared by incubating cortical microsomes with [ In the SHR, the blunted pressure-natriuretic response is associated with a reduction in papillary blood flow 3 and renal interstitial hydrostatic pressure. 4 Recent studies by Gebremedhin et al 5 suggest that the decline in papillary blood flow in adult SHR is due to an enhanced vascular tone rather than structural changes in the preglomerular vasculature of the deep nephrons. However, little is known about the renal vasculature of very young SHR, and it remains to be determined if changes in renal vascular reactivity occur very early in the development of hypertension.
P revious studies have indicated that the relation between arterial pressure and sodium excretion is shifted toward higher pressures before the development of hypertension in both spontaneously hypertensive rats (SHR) and Dahl salt-sensitive rats. 1 ' 2 In the SHR, the blunted pressure-natriuretic response is associated with a reduction in papillary blood flow 3 and renal interstitial hydrostatic pressure. 4 Recent studies by Gebremedhin et al 5 suggest that the decline in papillary blood flow in adult SHR is due to an enhanced vascular tone rather than structural changes in the preglomerular vasculature of the deep nephrons. However, little is known about the renal vasculature of very young SHR, and it remains to be determined if changes in renal vascular reactivity occur very early in the development of hypertension.
The factors responsible for elevating renal vascular tone in SHR are unknown. The recent findings that the expression of the cytochrome P-450 IVA2 gene 6 and the renal production of 20-hydroxyeicosatetraenoic acid are elevated in young SHR 7 
>
8 suggest that this system may be involved. This view is further supported by the observation that administration of heme arginate 9 or SnCl 2 , 1011 which lowers renal cytochrome P-450 activity, reduces arterial pressure in SHR. However, the mechanisms by which P-450 metabolites of arachidonic acid alter arterial pressure, renal function, or both are unknown. Recently, we have reported that cytochrome P-450 metabolites of arachidonic acid are produced by the renal microcirculation and that these compounds play a role in the myogenic response of renal arterioles to elevations in transmural pressure. 12 The purpose of the present study was to determine whether enhanced vascular tone occurs in the renal preglomerular vasculature of young SHR and to determine the possible contribution of cytochrome P-450 metabolites of arachidonic acid to the elevation in renal medullary vascular resistance previously observed in these animals.
Methods

Measurement of Arterial Pressure
Experiments were performed on 4-week-old SHR (88 ±5 g body weight) and Wistar-Kyoto (WKY) rats (102±4 g body weight) and Wistar-Lewis rats (98±4 g body weight) purchased from Harlan Sprague Dawley, Inc, Madison, Wis. The rats were housed in an animal care facility at the Medical College of Wisconsin approved by the American Association for Accreditation of Laboratory Animal Care and had free access to food and water throughout the study. All protocols involving animals were approved by the Animal Care Committee of the Medical College of Wisconsin. The rats were anesthetized with ketamine (25 mg/kg) and xylazine (1 mg/kg), and a catheter was implanted in the femoral artery for measurement of arterial pressure. The catheter was exteriorized at the back of the neck and brought out through a stainless-steel spring and swivel device. After a 2-day recovery period, arterial pressure was directly measured with a pressure transducer and recorded for 0.5 to 1.0 hour per day on 3 consecutive days while the animal was conscious with free movement in its cage. Heart rate and systolic, diastolic, and mean arterial pressures were determined and reduced to a single mean value for the entire recording period.
Pressure-Diameter Studies
These experiments were performed on 3-to 4-weekold SHR (70±5 g body weight), WKY (73±4 g body weight), and Wistar-Lewis (72 ±5 g body weight) rats. The renal vasculature of the Wistar-Lewis strain was studied to provide a second normotensive inbred control rat strain to compare with the SHR because of the evidence for genetic heterogeneity in the WKY rat 13 and its questionable adequacy as a control. The rats were anesthetized with pentobarbital (65 mg/kg body wt IP), and the left kidney was isolated and perfused for study of the juxtamedullary vasculature according to the method of Casellas and Navar 14 as modified by SanchezFerrer et al. 15 The kidney was perfused with a cell-free physiological salt solution (PSS) containing (mmol/L) NaCl, 116; CaCl 2 , 2.5; KC1, 5; MgCl 2 , 0.76; NaH 2 CO 3 , 24; glucose, 11; HEPES, 5; and 5% bovine serum albumin, which was supplemented with a mixture of L-amino acids to support tubular function. 16 The kidney was removed from the rat and placed in an organ chamber at 4°C throughout the isolation and dissection procedure to minimize ischemic injury.
Vascular diameters were measured with an epifluorescence microscope (model BHT, Olympus Corp, Tokyo, Japan) coupled to a video system composed of a high-sensitivity Newvicon camera (model WV-1910, Panasonic, Tokyo, Japan), a 15-in. television monitor (model TCI 115, RCA, Tokyo, Japan), a videocassette recorder (model DX-1000U, NEC, Tokyo, Japan), a video enhancer (Artek Systems Corp, New York, NY), and a video measuring system (model VIA-100, Boeckeler Instruments, Tucson, Ariz). The preparation was illuminated at 390 nm using a 100-W mercury vapor lamp, appropriate filters, and a dichroic mirror assembly. The incident light was passed through an infrared and a 50% neutral density filter to minimize heating of the preparation. The fluorescent image at wavelengths greater than 430 nm was observed using a x20 ultralong working objective (numeric aperture, 0.4). Precamera magnification was X62.5, and magnification to the screen was approximately x900.
The isolated vasculature was pressurized to 60 mm Hg and perfused and superfused with PSS equilibrated with 95% O 2 and 5% CO 2 (pH 7.4). Fluorescein isothiocyanate-labeled y-globulin (0.02%) was added to the perfusate to allow the vascular diameters to be measured with fluorescent videomicroscopy as previously described. 5 The temperatures of the perfusate and bath were slowly increased to 37°C, and after a 60-minute equilibration period the control relation between vascular diameter and perfusion pressure was determined at pressures of 60, 90, and 120 mm Hg. After the pressure was changed, an equilibration period of 5 minutes was allowed before new steady-state diameter measurements were obtained.
After the control pressure-diameter relation was determined, the effects of either ketoconazole (100 /u,mol/L, BIOMOL Research Laboratories Inc, Plymouth Meeting, Pa) or 7-ethoxyresorufin (7-ER, 1 fimolfL, Pierce Chemical Co, Rockford, 111), inhibitors of the cytochrome P-450 enzyme systems, on the pressure-diameter relations of the renal microvasculature of the SHR, WKY, and Wistar-Lewis rats were studied. Ketoconazole was dissolved in a 0.1 mmol/L HC1 stock solution and was diluted to a final concentration of 100 /xmol/L with PSS; the final pH of the perfusate was 7.35 to 7.4. 7-ER was dissolved in ethanol to a 2 mmol/L stock solution and diluted to a final concentration of 1 /umol/L with PSS. In these studies, diameter measurements were obtained after 30 minutes of perfusion of the preparations with the solution containing an inhibitor. Because the effects of the cytochrome P-450 inhibitors on the pressure-diameter relation were not significantly different, the data from these two groups were pooled and are presented together in Figs 1 through 3. After the effects of the P-450 inhibitors on vascular diameters were determined, the perfusate and bath were changed to a calcium-free solution, and the pressure-diameter relations were redetermined to assess the degree of active vascular tone in the preparation.
A separate series of experiments was performed examining the effects of ketoconazole (n=3) and 7-ER (n=3) on the renal microvascular vasoconstrictor response to norepinephrine (0.5 /imol/L) and the vasodilator response to acetylcholine (1 fimolfL). After control diameter measurements at a renal perfusion pressure of 90 mm Hg were made, changes in diameter 2 minutes after addition of norepinephrine and 2 minutes after the subsequent addition of acetylcholine were determined.
Assessment of Renal Cytochrome P-450-Dependent Metabolism of Arachidonic Acid
Previous studies have indicated that there are differences in cytochrome P-450 metabolism in young SHR vs WKY rats. 7 However, we felt it necessary to compare P-450 metabolism in young SHR, WKY, and WistarLewis rats because of the previously documented genetic differences in WKY rats obtained from different suppliers and questions regarding the adequacy of WKY rats as the sole normotensive control strain for SHR. 13 In addition, P-450 metabolism is dependent on age, sex, diet, and other environmental factors 17 ; there- fore, we felt it important to study P-450 metabolism of arachidonic acid in the same three groups of rats that were used in our renal microcirculatory studies. In these experiments, 3-to 4-week-old SHR, WKY, and WistarLewis rats were anesthetized with pentobarbital (65 mg/kg body wt IP). The kidneys were removed via laparotomy and placed in an ice-cold 0.9% sodium chloride solution. The renal cortex and outer medulla were dissected and homogenized in ice-cold potassium phosphate buffer (10 mmol/L, pH 7.7) containing 250 mmol/L sucrose, 1 mmol/L EDTA, and 0.1 mmol/L phenylmethylsulfonyl fluoride (PMSF). Renal microsomes were prepared by differential centrifugation to obtain microsomal pellets as previously described.
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The microsomes were suspended in potassium phosphate buffer (0.1 mol/L, pH 7.25) containing 30% (vol/vol) glycerol, 1 mmol/L EDTA, 1 mmol/L dithiothreitol, and 0.1 mmol/L PMSF, quick-frozen in liquid N 2 , and stored at -80°C until use.
Cytochrome P-450 activity was determined by incubating the microsomes (0.5 mg/mL) for 30 minutes at 37°C with 1 tiCilmL of [ l4 C]arachidonic acid (10 /xmol/L, Amersham Inc, Arlington Heights, 111) in potassium phosphate buffer (0.1 mol/L, pH 7.4) containing 10 mmol/L MgCl 2 , 1 mmol/L EDTA, 1 mmol/L NADPH, and an NADPH-regenerating system (20 mmol/L isocitrate and 0.1 U/mL isocitrate dehydrogenase). Control incubations were also performed without NADPH to test for the possible nonenzymatic metabolism of arachidonic acid. After 30 minutes, the reaction was terminated by acidification to pH 4.5 with 0.1 mol/L formic acid and extracted twice with 3 mL ethyl acetate. The combined organic phase was back extracted with 1 mL distilled water to remove residual acid. The extracts were evaporated to dryness under N 2 and reconstituted in 500 /U.L ethanol.
Metabolites were separated with a 2 mmx25 cm C18 reversed-phase high-performance liquid chromato- 
Statistics
Data are presented as mean±SEM. The significance of differences of mean values between groups was evaluated with two-way analysis of variance for repeated measures followed by a Duncan's multiple range test. One-way analysis of variance followed by the Bonferroni test was used to determine the significance of differences in mean arterial pressure and cytochrome P-450 metabolite production rates between the groups. 18 A value of P<.05 was considered to be statistically significant.
Results
Measurement of Arterial Pressure
Mean arterial pressure averaged 126±2 mm Hg in conscious 4-week-old SHR (n=9) and 113±4 mm Hg in WKY (n=7) and 103+3 mm Hg in Wistar-Lewis (n=6) rats. SHR had a significantly (P<.05) elevated mean arterial pressure compared with WKY and WistarLewis rats. Fig 1 summarizes diameter relations of the renal interlobular arteries. Under control conditions (Fig 1, left) , the diameter of the interlobular artery of the SHR was significantly smaller than the corresponding vessels measured in WKY and Wistar-Lewis rats. The diameters of the interlobular arteries decreased by 4% in the WKY rats and SHR but did not change significantly in WistarLewis rats when perfusion pressure was elevated from 60 to 120 mm Hg. Addition of the P-450 inhibitors to the perfusate had no effect on the basal diameter (Fig 1,  middle) of the interlobular arteries (measured at 60 mm Hg), but it did alter the response of the interlobular artery from a slight decrease to a significant 5% increase in diameter when perfusion pressure was elevated from 60 to 120 mm Hg in SHR and Wistar-Lewis rats. Removal of calcium from the bath and perfusate (Fig 1, right) further dilated the interlobular arteries in SHR and Wistar-Lewis rats. WKY rats exhibited the least amount of active vascular tone under control conditions, as the basal diameter of the interlobular artery increased by only 2% in calcium-free media. Wistar-Lewis rats exhibited an intermediate degree of active vascular tone as the interlobular artery diameter increased by 8%, and SHR exhibited the greatest amount of vascular tone as the basal diameter of the interlobular artery increased by 13%. The differences in the pressure-diameter relation between SHR and WKY rats were completely eliminated by removal of calcium from the medium, and the passive diameter of the interlobular artery was greater in the Wistar-Lewis than in the WKY rats or SHR.
Pressure-Diameter Studies
The results comparing the pressure-diameter relations of the proxipial afferent arterioles in SHR and normotensive rats' are presented in Fig 2. The basal diameters of the proximal afferent arteriole in SHR were smaller than corresponding diameters observed in WKY and Wistar-Lewis rats by 9% and 8%, respectively (Fig 2, left) . The proximal portion of the afferent arterioles exhibited similar significant reductions (4% to 7%) in diameter in all three groups when pressure was elevated from 60 to 120 mm Hg. Addition of P-450 inhibitors to the perfusate increased the basal diameter of the proximal afferent arteriole by 7% in SHR (Fig 2,  middle) . In contrast, the diameter of the proximal afferent arteriole in WKY and Wistar-Lewis rats increased by only 0% and 2%, respectively. Inhibitors of P-450 eliminated the differences in the pressure-diameter relations of the proximal afferent arterioles in SHR and normotensive rats. In all three groups, administration of the P-450 inhibitors completely eliminated the vasoconstrictor response of the proximal afferent arteriole to elevations in perfusion pressure. Calcium-free media further increased the basal diameters and eliminated differences in the pressure-diameter relations of the proximal afferent arteriole in all three groups (Fig 2,  right) . Similar to the results obtained in the interlobular artery, the SHR had a much larger active tone in the afferent arteriole than the normotensive rats.
The effects of cytochrome P-450 inhibitors and calcium-free media on the pressure-diameter relations of the distal afferent arteriole in SHR and normotensive rats are presented in Fig 3. Under control conditions, the basal diameters of the distal afferent arterioles in SHR were smaller than corresponding diameters observed in WKY and Wistar-Lewis rats by 8% and 16%, respectively (Fig 3, left) . Elevation of perfusion pressure from 60 to 120 mm Hg reduced the diameter of the afferent arterioles in all three groups. Addition of cytochrome P-450 inhibitors to the perfusate significantly increased the basal diameters of the distal afferent arterioles of SHR and Wistar-Lewis rats (Fig 3, middle) and had no effect on the diameters of these vessels in WKY rats. Inhibitors of P-450 partially eliminated the differences in the pressure-diameter relations between SHR and WKY rats; however, the SHR diameter remained smaller than that of the Wistar-Lewis rats after addition of P-450 inhibitors. In all three groups, administration of the P-450 inhibitors greatly attenuated the vasoconstrictor response of the distal afferent arteriole to elevations in perfusion pressure. Calcium-free media increased distal afferent arteriole diameters in all three groups, and there was no significant difference in the pressure-diameter relations between SHR and WistarLewis rats (Fig 3, right) . Again, the WKY rats had the least amount of active tone, and the passive diameter of the distal afferent arteriole of the WKY was smaller than that of the SHR and Wistar-Lewis rats.
In a separate group of experiments, the influences of ketoconazole and 7-ER on the vasoconstrictor response to norepinephrine and the vasodilator response to acetylcholine on the renal microvessels were examined. Inhibition of cytochrome P-450 activity had no effect on either the vasoconstrictor response to norepinephrine or on the relaxant response to acetylcholine. Norepinephrine reduced the diameter of renal microvessels by 19.8±2.9% before and 16.2±3.3% ( n = l l vessels) and 18.4±2.2% (n = 10) after treatment with ketoconazole and 7-ER, respectively. Similarly, acetylcholine increased vascular diameters by 27.4±3.5% before and by 25.6±3.2% (n=ll) and 31.5±3.9% (n=10), respectively, after inhibition of renal P-450 activity with ketoconazole and 7-ER.
Cytochrome P-450 Metabolism of Arachidonic Acid
Representative chromatograms of metabolites of arachidonic acid produced by renal cortical microsomes of SHR and WKY rats are presented in Fig 4. The products with retention times of 8.5 and 9.5 minutes coeluted with authentic 14,15-and 11,12-dihydroxyeicosatrienoic acid (DIHETE, top) standards, respectively. The metabolites that eluted at 11, 17.5, and 19 minutes coeluted with 20-HETE, 14,15-, and 11,12-epoxyeicosatrienoic acid (EET) standards, respectively (bottom). This example illustrates the major differences in production of P-450 metabolites of arachidonic acid by renal cortical microsomes of SHR and WKY rats; ie, SHR exhibited elevated production of 20-HETE, 11,12-, and 14,15-DIHETE and reduced production of 11,12-and 14,15-EET relative to WKY rats. The retention times of authentic 8,9-and 5,6-EET standards were 20.1 and 21 minutes on this system, and we obtained no evidence for significant formation of these metabolites by renal cortical microsomes in the present study.
A summary of the production of the major P-450 metabolites of arachidonic acid by renal microsomes of normotensive and hypertensive rats is presented in Fig  5. The production of 20-HETE was 59% higher in SHR and 47% higher in Wistar-Lewis rats than in WKY rats. In WKY rats, the production of 11,12-EET was 10 times greater and the production of 11,12-DIHETE was 75% less than observed in the SHR and Wistar-Lewis rats. Incubation of the renal cortical microsomes with either ketoconazole (100 /rniol/L) or 7-ER (1 jtmol/L) resulted in a marked inhibition of P-450 metabolites of arachidonic acid in all three groups (Fig 6) . Ketoconazole inhibited the production of 20-HETE by 86% and DIHETEs and EETs by more than 95% similarly in all three groups. 7-ER reduced 20-HETE formation by 80% and the production of DIHETEs and EETs by 75% and 85%, respectively, in all three groups.
Discussion
An abnormality in renal function that occurs very early in the development of hypertension in SHR has been identified. Papillary blood flow is reduced and the pressure-natriuretic response is blunted in young SHR, 1 such that the kidneys of these animals require an elevated pressure to achieve sodium and water excretion rates equivalent to those seen in WKY rats. We have previously reported that preglomerular vascular tone is elevated in deep nephrons in 12-week-old adult SHR. 5 This abnormality could provide a possible explanation for previously observed alterations in vasa recta hemodynamics and the resetting of the pressure-natriuretic relation in these animals. 13 However, direct studies of the renal microcirculation have not been performed in young SHR very early in the development of hypertension. Thus, the question of whether the elevation in preglomerular renal vascular tone previously observed in the adult SHR was the cause or consequence of hypertension remains unresolved. In addition, the factors contributing to the elevation in preglomerular vascular tone in deep nephrons of young SHR have not been studied previously. Recent findings that P-450 IV A2 gene expression 6 and production of vasoactive P-450 metabolites of arachidonic acid are elevated in young SHR 7 suggest that this system may be Time (minutes) involved. The present study examined whether changes in renal vascular tone are apparent early in the development of hypertension in young SHR and evaluated the potential contribution of P-450 metabolites of arachidonic acid to the altered vascular tone in these animals.
In the present study we examined the preglomerular vasculature in young SHR. We found that the internal diameters of the interlobular artery and proximal and distal portions of the afferent arterioles of juxtamedullary glomeruli were significantly smaller in young SHR than the diameters of corresponding vessels in agematched WKY and Wistar-Lewis rats at all perfusion pressures studied. In SHR, removal of calcium from the perfusion and superfusion solutions dilated the entire preglomerular vasculature to a greater extent in SHR than in normotensive rats and eliminated the differences in the pressure-diameter relations between SHR and normotensive rats. These results indicate that the smaller diameters of the renal preglomerular vasculature of young SHR vs normotensive rats are due to differences in active vascular tone rather than a structural narrowing of the vessels. Previous studies have demonstrated an increased cerebral vascular tone in young SHR, 19 and studies of the skeletal muscle microcirculation have shown an increased vascular resistance 20 -22 that was due, in part, to vascular rarefaction. 22 The present study is the first to observe directly an increase in active renal vascular tone as early as 4 weeks in the SHR. Our observations are consistent with previous reports indicating that renal vascular resistance and vascular reactivity to vasoconstrictors are elevated in young SHR 23 -25 and that these differences occur before the development of major structural changes in the renal vasculature. 11, 11, 11, 11, sure would require an elevated perfusion pressure to normalize the pressure-natriuretic relation in young SHR. Thus, the elevated mean arterial pressure observed in young SHR may be required to normalize papillary blood flow and renal interstitial hydrostatic pressure and to maintain sodium balance.
The factors responsible for elevating vascular tone in the kidney of SHR are unknown. Presumably, this must be a local factor because our observations were made in an in vitro preparation. In the present study, cytochrome P-450 inhibitors produced a greater dilation in the afferent arteriole of SHR than in normotensive rats and partially eliminated the differences in pressurediameter relations in the preglomerular vasculature of normotensive and hypertensive rats. These results indicate that P-450 metabolites of arachidonic acid contribute to the elevated vascular tone of young SHR.
Cytochrome P-450 inhibitors also attenuated the pressure-dependent vasoconstriction of the afferent ar- terioles in all groups. This observation is consistent with the results of a recent study indicating that arachidonic acid potentiates and P-450 inhibitors block the myogenic response of isolated perfused dog renal arteries to elevations in transmural pressure. 12 Our present findings also suggest that cytochrome P-450 metabolites of arachidonic acid may participate in renal autoregulatory responses of the afferent arteriole of rats to changes in perfusion pressure.
To determine the P-450 metabolites of arachidonic acid that could possibly contribute to the alterations in renal vascular tone in SHR, we compared the metabolism of arachidonic acid in renal cortical microsomes of SHR and normotensive rats. We confirmed previous findings 7 -8 that 20-HETE is the major P-450 metabolite of arachidonic acid produced by renal cortical microsomes and that the production of this metabolite is increased in young SHR compared with WKY rats. 7 In previous studies we found that isolated dog renal arteries can synthesize 20-HETE and that 20-HETE is a potent vasoconstrictor of renal arteries. 27 More recently, we have found that 20-HETE has a dose-related vasoconstrictor effect on preglomerular vessels in the juxtamedullary nephron preparation. 28 Thus, it is possible that the enhanced production of 20-HETE in SHR may be involved in elevating renal vascular tone particularly in the deep nephrons, lowering papillary blood flow and resetting the pressure-natriuresis relation previously observed in these animals. This mechanism is consistent with previous observations that the expression of the P-450 IVA2 gene 6 and P-450 w-hydroxylase activity is elevated 7 before development of hypertension in young SHR. It also provides a mechanism to explain how administration of SnCl 2 to induce heme oxygenase and lower renal P-450 activity 11 might promote sodium excretion at lower levels of pressure and prevent the development of hypertension.
We also observed large differences in the production of 11,12-EET and 11,12-DIHETE between SHR and WKY rats. 11,12-EET is a vasodilator 29 -30 and 11,12-DIHETE is a less active breakdown product; this shift from EETs to DIHETEs could possibly contribute to the differences in vascular tone observed. The renal vascular effects of these substances and how they may contribute to the differences in vascular tone between SHR and WKY rats remain to be determined.
Because of the molecular evidence of genetic heterogeneity in the normotensive WKY rat, 13 it may not be an adequate control strain for the SHR. Therefore, we also compared diameters of the preglomerular vasculature in SHR with those observed in a second normotensive inbred rat strain. SHR rats exhibit an enhanced preglomerular renal vascular tone compared with Wistar-Lewis rats. In addition, the differences in the pressure-diameter relations between SHR and Wistar-Lewis rats, like WKY rats, are partially eliminated by cytochrome P-450 inhibitors, indicating that P-450 metabolites contribute to the differences in renal vascular tone between these strains. In contrast to WKY rats, the metabolism of arachidonic acid by cytochrome P-450 in renal cortical microsomes is not significantly different between SHR and Wistar-Lewis rats. These observations suggest that differences in the responsiveness of the renal vasculature to 20-HETE and other P-450 fatty acid metabolites rather than differences in metabolite levels may contribute to the differences in vascular tone in SHR and Wistar-Lewis rats. In contrast, both an increased production of 20-HETE as well as an enhanced responsiveness to a P-450 metabolite may contribute to the differences observed between SHR and WKY rats. Supporting this concept is the observation that cytochrome P-450 inhibition had the largest dilator effect on the preglomerular vasculature of SHR, an intermediate effect on that of Wistar-Lewis rats, and a very small effect on WKY preglomerular basal vascular diameters.
In summary, the present results suggest that active preglomerular vascular tone in deep nephrons is elevated in young SHR. The production of the renal vasoconstrictor 20-HETE is elevated in young SHR compared with WKY rats, and cytochrome P-450 inhibitors eliminated the differences in vascular tone in afferent arterioles of normotensive and hypertensive rats. These results suggest that cytochrome P-450 metabolites may contribute to the elevated preglomerular renal vascular tone in deep nephrons of young SHR and may play a role in altering papillary blood flow and resetting the pressure-natriuretic relation previously observed in these animals. 
